Showing results (21-30 of 105) with videos related to
Sort By:
Pageof 11
American Journal of Clinical Oncology|October 24, 2002
Phase I/II trial of accutane as a potentiator of carboplatin and paclitaxel in squamous cell carcinomasRobert Wieder, Anna C Pavlick, Margarette Bryan, et al.Chemotherapy|May 20, 2009
Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanomaPatrick A Ott, Jason L Chang, Ruth Oratz, et al.NPJ Precision Oncology|June 19, 2020
Decreased cytotoxic T cells and TCR clonality in organ transplant recipients with squamous cell carcinomaNicholas Frazzette, Alireza Khodadadi-Jamayran, Nicole Doudican, et al.Cancer Treatment Reviews|July 10, 2017
Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their managementMario Sznol, Michael A Postow, Marianne J Davies, et al.Journal of Translational Medicine|July 16, 2010
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032Jill C Rubinstein, Mario Sznol, Anna C Pavlick, et al.Oncology|January 25, 2012
Enrollment in clinical trials correlates with improved survival in metastatic melanomaNagashree Seetharamu, Ting J Tu, Paul Christos, et al.Oncology|July 27, 2017
Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the LiteratureKierstin Utter, Chloe Goldman, Sarah A Weiss, et al.Cancer|January 2, 2009
Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm)Melanie A Warycha, Jan Zakrzewski, Quanhong Ni, et al.Investigational New Drugs|April 9, 2016
A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanomaShailender Bhatia, Anna C Pavlick, Peter Boasberg, et al.JAMA Dermatology|March 5, 2017
Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With PembrolizumabMary L Stevenson, Claire Q F Wang, Melody Abikhair, et al.Pageof 11